Nephrology

Dr. Matthew Weir discusses the pros and cons of SGLT-2 drugs with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas. Dr. Matthew Weir, MD is a professor of medicine and director of Nephrology in the Department of Medicine at the University of Maryland. Dr. ...

Dr. Matthew Weir talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the impact of SGLT2 drugs on the possible improvement of kidney disease. Dr. Matthew Weir, MD is a professor of medicine and director of Nephrology in the Department of Medicine ...

At the the AACE 2017 convention in Austin, Texas, Dr. Matthew Weir and Diabetes in Control Publisher Steve Freed discuss the impact of SGLT2 drugs in helpful as well as possibly harmful ways. They also look at the need for safety studies for kidney disease. Dr. Matthew Weir, MD is ...

At the AACE 2017 convention in Austin, Texas, Dr. Matthew Weir talks with Diabetes in Control Publisher Steve Freed about how he detects kidney disease in an effort to catch and treat the condition in its early stages. Dr. Matthew Weir, MD is a professor of medicine and director of ...

Study looks at the heterogeneity of CKD in type 1 diabetes.

Big changes to affect small vessels.

In this week's Homerun Slides, determining therapeutic approaches for patients with type 2 and chronic kidney disease.

Condition often under-recognized, yet preventable and treatable.

Changes in serum metabolomic profile affect eGFR in patients with type 1 diabetes.

In this week's Homerun Slides, recognizing the role of Glycocalyx in microvascular and macrovascular dysfunction.